Here is the analysis and key aspects for the supplier regarding the tender “Medicinal product with the active substance burosumab” (reference number 313094):

Subject of the tender

• Product: Burosumab (active substance), used for the treatment of a child with X-linked hypophosphatemia.
• Technical requirements:
  • The medicinal product must be offered in three strengths (10 mg/ml, 20 mg/ml, and 30 mg/ml).
  • The medicinal products must be compatible with each other for one…
     
    To see full summary, please log in or register.

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?